| Authors: |
Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Knelson EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wolff JO; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Vajdi A; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Saigí M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Campisi M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy., Hong D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Thai TC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Piel B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Han S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Reinhold BB; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Duke-Cohan JS; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Poitras MJ; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, Massachusetts., Taus LJ; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Lizotte PH; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Portell A; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Quadros V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Santucci AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Murayama T; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Cañadas I; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Kitajima S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Cell Biology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Akitsu A; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Fridrikh M; Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Watanabe H; Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Reardon B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gokhale PC; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, Massachusetts., Paweletz CP; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Awad MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lako A; Translational Pathology, Bristol Myers Squibb, Trenton, New Jersey., Wang XT; Translational Pathology, Bristol Myers Squibb, Trenton, New Jersey., Chen B; Translational Pathology, Bristol Myers Squibb, Trenton, New Jersey., Hong F; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Tolstorukov MY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Pfaff K; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gjini E; Translational Pathology, Bristol Myers Squibb, Trenton, New Jersey., Edwards R; Translational Pathology, Bristol Myers Squibb, Trenton, New Jersey., Rodig S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Reinherz EL; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Oser MG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. david_barbie@dfci.harvard.edu matthew_oser@dfci.harvard.edu., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. david_barbie@dfci.harvard.edu matthew_oser@dfci.harvard.edu. |
